| Identification | Back Directory | [Name]
Duoperone | [CAS]
62030-88-0 | [Synonyms]
Methanone, (4-fluorophenyl)[1-[3-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]propyl]-4-piperidinyl]- | [Molecular Formula]
C28H26F4N2OS | [MDL Number]
MFCD00867755 | [MOL File]
62030-88-0.mol | [Molecular Weight]
514.58 |
| Chemical Properties | Back Directory | [Boiling point ]
613.5±55.0 °C(Predicted) | [density ]
1.289±0.06 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
Soluble in DMSO | [pka]
8.12±0.10(Predicted) |
| Hazard Information | Back Directory | [Uses]
Neuroleptic. | [in vivo]
Duoperone blocks d-amphetamine lethality in mice under aggregated conditions when the pretreatment interval is between one hour and seven days. ABR-6646 produces catalepsy in rats. The onset of this effect is delayed and the duration is prolonged when compared with that of chlorpromazine. Apomorphine-induced pivoting in mice with unilateral lesions of the caudate nucleus is suppressed by ARR-6646[1]. |
|
|